Public annual accounts

PHARM-AD financials

Name: PHARM-AD financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for PHARM-AD, with comparable measures and links to available source documents.

Company overview

Registry number

0819236165

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for PHARM-AD

2025 versus 2024

Operating line: €222,322
EBITDA: €220,594
Total assets: €659,306
Equity: €476,654

EBITDA margin +99.2% · Equity ratio +72.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Jun 2025	€222,322	€220,594	€659,306	€476,654	-
202430 Jun 2024	€265,434	€261,867	€732,939	€473,184	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report